PCM
CL icon

Prelude Capital Management’s Colgate-Palmolive CL Stock Holding History

Prelude Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,200
Closed -$4.29M – 1570
2020
Q4 		$4.29M Buy
+50,200
New +$4.15M 0.11% 131
2020
Q3 		– Sell
-50,200
Closed -$3.68M – 1886
2020
Q2 		$3.68M Hold
50,200
– – 0.2% 70
2020
Q1 		$3.33M Buy
50,200
+200
+0.4% +$14.1K 0.22% 57
2019
Q4 		$3.44M Buy
+50,000
New +$3.41M 0.13% 104
2019
Q1 		– Sell
-47,500
Closed -$2.83M – 1787
2018
Q4 		$2.83M Buy
+47,500
New +$2.97M 0.19% 108

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Prelude Capital Management's CL Position: Q2 2025 in Review

Prelude Capital Management sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,409 shares — an estimated $226K sold.

Prelude Capital Management first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $3.99M in Q2 2020. 1,914 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Prelude Capital Management reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 2,409 Colgate-Palmolive shares in Q2 2025, an estimated $226K.
  • Prelude Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
  • Prelude Capital Management's Colgate-Palmolive position peaked at $3.99M in Q2 2020.
  • 1,914 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.